Frontiers P2RY12-Inhibitors Reduce Cancer-Associated Thrombosis and Tumor Growth in Pancreatic Cancers
Por um escritor misterioso
Descrição
Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia
IJMS, Free Full-Text
Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia
PDF) P2RY12-Inhibitors Reduce Cancer-Associated Thrombosis and Tumor Growth in Pancreatic Cancers
PDF) Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells
Metabolic symbiosis in pancreatic cancer
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma - ScienceDirect
Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade
Frontiers P2RY12-Inhibitors Reduce Cancer-Associated Thrombosis and Tumor Growth in Pancreatic Cancers
The role of coagulation and platelets in colon cancer-associated thrombosis
P2Y12 Receptor Modulates Sepsis-Induced Inflammation
PDF) Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells
Frontiers Extracellular DNA Traps: Origin, Function and Implications for Anti-Cancer Therapies
Inflammasomes in breast cancer: the ignition spark of progression and resistance?, Expert Reviews in Molecular Medicine
de
por adulto (o preço varia de acordo com o tamanho do grupo)